• 2020 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsJoin us at the 2020 GAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    April 14-18, 2020, Honolulu, HI.

    Earn up to 18 CNE hours.


    Find out more about it and REGISTER today!

  • 2019 Senior Report Senior Report: Older Americans have more options for home care, but still struggling.

    The United Health Foundation has released results of a sweeping new study benchmarking the health of older adults. The America's Health Rankings® Senior Report was created in partnership with GAPNA to improve the health of America's seniors.

    The data will help advanced practice nurses and other providers deliver quality care.

    Find out about it!

  • AwardNew for GAPNA members: MCM Education

    GAPNA has partnered with a MCM Education to offer an ongoing series of CNE programs available to GAPNA members. "Diagnosing and Managing Parkinson’s Disease in Older Adults," is the latest program offered.

    Parkinson’s disease (PD) is characterized by both motor and nonmotor symptoms. It is diagnosed based on the presence of two of four motor symptoms including rest tremor, bradykinesia, rigidity, and gait imbalance...

    Find out about it!

  • FREE continuing education credit is available for the following session:

    "Dementia Management Update"

    (session captured at the GAPNA 2018 Annual Conference)

    For September/October 2019 - Get Your Free CNE Now!

Antipsychotic Choices in Nursing Homes Partly Influenced by Nursing Home’s Prescribing Culture

A new study reveals the majority of nursing homes favor treating patients with atypical antipsychotics.

Using a variety of data sources, including Medicaid and Medicare data, the researchers identified 65,618 patients 65 years or older residing in nursing homes in 45 states.

All had started treatment with an antipsychotic after their admission between 2001 and 2005.

Nearly half of the nursing homes studied (45%) never prescribed a conventional antipsychotic medication.

In fact, 91.2% of patients started treatment with an atypical medication. Of the 8.8% of patients treated with a conventional medication, the most frequently prescribed drugs were haloperidol (86%) and chlorpromazine (8%).

See the complete study at Huybrechts, K.F. et al. (2012). Variation in antipsychotic treatment choice across US nursing homes. Journal of Clinical Psychopharmacology, 32(1), 11-17.

Related Topic 1: 

GAPNA Newsletter Issue: